Ipratropium Bromide Aerosol is a bronchodilator.
Ipratropium Bromide Aerosol is an anticholinergic bronchodilator indicated for the prevention and treatment of dyspnea associated with chronic obstructive airway disease. Use requires spray inhalation, and patients are advised to sit or stand while inhaling. The exact dosage and frequency of use need to be individualized by the doctor according to the patient’s age and condition.
Some patients may experience adverse reactions such as headache, nausea, dry mouth, etc., and may have allergic reactions such as skin rash and tongue, lip and urticaria, etc. If the symptoms are severe, they should consult a doctor and be treated accordingly.
Breastfeeding, pregnant women and children need to use this drug with caution, closed-angle glaucoma, prostate hypertrophy, pyloric obstruction patients need to be prohibited from use.
Patients follow the doctor’s instructions to use the drug, not blindly self-use, so as not to treat the ineffective or delay the condition.